Segmentectomy After Induction Therapy (SAINT)

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT06496659
Status
Recruiting
Apply to this trial

Conditions

  • Segmentectomy

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Segmentectomy — PROCEDURE
    A segmentectomy is a surgical procedure to remove a segment of the lung. This surgery will be done on patients who have completed neoadjuvant therapy for diagnosis of Non-Small Cell Lung Cancer.

Study Details

The primary objective will be to determine the feasibility of performing a high-quality sublobar anatomic resection (segmentectomy) with R0 margin status on final pathology for patients who received induction therapy for NSCLC and are downstaged to ≤ycT1cN0M0 (TDi 3cm or less). T1c is tumor staging 1 and c stands for tumor is considered larger than 2cm but no larger than 3cm across; N0 is No regional lymph node metastasis; M0 is No distant metastasis.

Key Dates

Start date
Aug 2, 2024
Status verified
May 2026
Primary completion
Jul 30, 2029
Completion
Jul 30, 2029

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Segmentectomy after Induction Therapy
    Surgical intervention (segmentectomy) post induction therapy for Non-Small Cell Lung Cancer

Primary Outcome Measure

Number of participants with Segmentectomy and R0 on final pathology [ Time Frame: Up to 48 hours after date of surgical resection ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Northwestern UniversityChicagoIllinois60611
Ankit Bharat, M.D.
[email protected]
312-926-7628
Nisha Palanisamy
[email protected]
312-926-7577

Find similar trials in Chicago, IL

By research site
Northwestern University· Chicago, IL

Related Studies